Healthcare forecasters might assume that because of demographics, heart disease would be a leading cause of increased demand for hospital services-and, therefore, healthcare costs.
Surprisingly, however, cardiac disease and specifically heart attacks, have been the second-fastest declining hospitalization since 2003, according to one industry expert.
"This is occurring despite an aging population and more patients being diagnosed with heart diseases," says Kaveh Safavi, MD, JD, chief medical officer, Thomson Healthcare. "Other research suggests that long-term population treatment of risk factors for heart disease and treatment of newly diagnosed heart disease leads to stable heart disease that does not result in hospital stays-but does consume outpatient resources."
While the cardiac category is still an important condition in absolute terms relative to costs and hospital admissions, its relative position is declining. "Medical conditions such as infection are becoming increasingly important causes of hospitalization, as are joint replacements," he says. "We also have found that more patients in the hospital had heart disease in 2006 versus 2003, but that is not the reason for their hospitalizations."
The increasing rate of hospitalization for kidney disease, which has not been widely understood, might hold the biggest surprise. "In absolute terms, kidney disease is not yet a large part of the hospitalization picture, but some research has shown that it will be the fastest growing disease between now and 2025," Dr. Safavi says. "The United States has a real shortage of kidney specialists given the increasing demand.
"Population trends alone do not predict demand on future cost," Dr. Safavi adds. "We often think about technology as adding cost, but we may have evidence that in the long run, changing the natural history of diseases will change the cost and demand curves, also."
Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis
July 8th 2025AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and psoriasis driven by Th17 inflammation. However, newer research has shown that these diseases can overlap in patients and may even share common pathways.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Autoimmune Diseases Almost Double Mental Health Disorder Risk
July 7th 2025The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depression, anxiety disorder and bipolar disorder.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen